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Background
In clinical trials the selection of appropriate outcomes is
crucial to the assessment of whether one intervention is
better than another. Glaucoma is a chronic eye disease
and the leading cause of irreversible blindness in the
world. A variety of outcomes has been used and reported
in glaucoma RCTs.
Objectives
The purpose of this review is to identify different clinical
outcome measures used in glaucoma RCTs between
January 2006 and March 2012.
Methods
A systematic review was conducted using standard
methodology. We searched for RCTs in glaucoma pub-
lished in English with no restrictions on the population
type or size, or applied interventions. All clinical out-
comes were included. Patient-reported, pharmacokinetic
and economic outcomes were excluded.
Results
The search strategy identified 4288 potentially relevant
abstracts. There were 315 publications retrieved, of
which 233 RCTs were included. A total of 967 clinical
measures were reported. There were large variations in
the definitions used to describe different outcomes and
their measures. Intraocular pressure (IOP) was the most
commonly reported outcome (used in 201 RCTs, 86%)
with a total of 422 measures (44%). Amongst the IOP-
related measures, the most commonly used was mean
IOP (n=143, 15% of all measures). Safety outcomes were
commonly reported, in 145 RCTs (62%) whereas visual
field outcomes were utilized in 38 RCTs (16%).
Conclusions
There is a large variability in clinical outcomes used for
glaucoma RCTs and in the way each outcome is
reported. This lack of standardisation may impair the
ability to evaluate the evidence of glaucoma interventions.
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